Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing lithium dosing in hemodialysis.

N H Bjarnason1, R Munkner, J P Kampmann

  • 1Department of Clinical Pharmacology, Rigshospitalet, Copenhagen, Denmark. nina.bjarnason@rh.dk

Therapeutic Drug Monitoring
|April 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2022
Same author

Challenges in conducting paediatric trials with off-patent drugs.

Contemporary clinical trials communications·2021
Same author

Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade.

Infection·2021
Same author

[Community-acquired pneumonia].

Der Pneumologe·2020
Same author

Higher chlorzoxazone clearance in obese children compared with nonobese peers.

British journal of clinical pharmacology·2018
Same author

[Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia - Update 2017 - S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology].

Pneumologie (Stuttgart, Germany)·2018
Same journal

A Novel Dosing Strategy for Tacrolimus in Lung Transplant Recipients: Integrating Machine Learning with Population Pharmacokinetic Analysis.

Therapeutic drug monitoring·2026
Same journal

Recommendations for Assessing Methodological Quality in Systematic Reviews of Population Pharmacokinetic Models: A Systematic Review.

Therapeutic drug monitoring·2026
Same journal

Wide-Range Quantification of Belumosudil in Patients with Chronic Graft-Versus-Host Disease by High-Performance Liquid Chromatography.

Therapeutic drug monitoring·2026
Same journal

Deltamethrin Placental Transfer and Seasonal Pyrethroid Exposure: A Mother-Newborn Dyad Pilot Study.

Therapeutic drug monitoring·2026
Same journal

A Clustering-Based Grey Modeling Approach for Tacrolimus Concentration Prediction Under Sparse Therapeutic Drug Monitoring.

Therapeutic drug monitoring·2026
Same journal

Response to Panteghini "About Analytical Performance Specifications for Immunosuppressive Drug Measurements".

Therapeutic drug monitoring·2026
See all related articles

This study shows that lithium carbonate therapy can be safely initiated and maintained in hemodialysis patients. A specific post-dialysis dosing regimen achieved stable therapeutic lithium levels without adverse effects, improving depressive symptoms.

Area of Science:

  • Pharmacology
  • Nephrology
  • Psychiatry

Background:

  • Lithium carbonate is used to treat bipolar disorder and depression.
  • Patients with end-stage renal disease (ESRD) requiring hemodialysis often have altered drug pharmacokinetics.
  • Determining appropriate lithium dosing in hemodialysis patients is challenging due to impaired kidney function.

Observation:

  • A 62-year-old female hemodialysis patient was initiated on lithium carbonate therapy.
  • Three methods were used to estimate lithium dosage: volume of distribution (Vd), glomerular filtration rate (GFR), and a pharmacokinetic model.
  • The GFR-based estimate resulted in sub-therapeutic lithium levels.

Findings:

  • Estimates based on Vd and pharmacokinetic modeling yielded comparable loading doses.

Related Experiment Videos

  • A maintenance dose derived from the central compartment volume (V1) achieved therapeutic plasma lithium concentrations.
  • A regimen of 12.2 mmol lithium administered post-hemodialysis resulted in stable, therapeutic lithium levels over 8 months.

    • Implications:

    • Hemodialysis patients with no residual kidney function can be safely treated with lithium carbonate administered immediately post-dialysis.
    • This approach may offer a viable treatment option for depression in ESRD patients.
    • Further long-term studies are needed to confirm safety and optimize monitoring protocols.